Xience Versus Synergy in Left Main PCI

NAUnknownINTERVENTIONAL
Enrollment

818

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2020

Conditions
Coronary Artery Disease
Interventions
DEVICE

Percutaneous coronary intervention

Percutaneous coronary stent implantation

DRUG

Dual antiplatelet therapy

Dual antiplatelet therapy with aspirin and either clopidogrel, prasugrel or ticagrelor will be recommended for 12 months duration in the Xience stent arm but only 4 months duration in the Synergy stent arm.

All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

collaborator

Venn Life Sciences

OTHER

collaborator

Cardialysis B.V.

INDUSTRY

collaborator

Diagram B.V.

OTHER

lead

NHS National Waiting Times Centre Board

OTHER

NCT02303717 - Xience Versus Synergy in Left Main PCI | Biotech Hunter | Biotech Hunter